🌏 中文版
Deal Terms
| Item | Value |
|---|---|
| Company | Vocca (New York, US / Paris, France) |
| Round | Series A |
| Amount | $20M |
| Lead | Norrsken VC |
| Participants | Heal Capital, Speedinvest, Firstminute Capital, and angel investors including the founders of Alan and Datadog |
| Valuation | Undisclosed |
| Total raised | $25M ($5.5M seed co-led by Speedinvest and Firstminute Capital in September 2025 + this $20M round) |
| Founded | 2024 |
| Headcount | ~40 across New York and Paris, planning to hire 40 more by end of 2026 |
What the Company Does
Vocca builds AI voice agents for medical practices — specialized agents that answer patient phone calls and handle scheduling, rescheduling, and routine questions, replacing the front-desk staff clinics typically need just to keep up with the phone.
Its end-to-end voice agents now cover more than 20 medical specialties across over 1,500 practices, handling more than a million patient interactions a month. The company says 70% of conversations are resolved without any human involvement, rising above 85% for its top customers. It plans to use this round to build out its scheduling infrastructure, add communication channels beyond voice, handle more complex cases, and push deeper into the US market.
The number of practices it serves grew from 2,000 to 15,000 in a year, making it one of the fastest-growing companies in healthcare voice agents. Its closest competitor, Prosper AI, raised a $30M Series A led by a16z and has raised about $35M total.
What This Round Signals
What It Means for the Agent Ecosystem
Clinic phone calls are repetitive, high-volume, and have almost no tolerance for error — exactly the kind of setting where voice agents are now proving they can replace human labor at scale, not just impress in a demo. The task boundaries are clear (book, reschedule, answer routine questions) and failure is easy to measure (a missed call, a wrong appointment), which makes this an easier proving ground than open-ended customer-service conversations.
What Investors Are Betting On
Norrsken VC has long focused on tech companies that create positive social impact, and freeing up healthcare staff who'd otherwise be answering phones to instead focus on patient care fits that thesis directly. Speedinvest and Firstminute Capital backed Vocca's 2025 seed round and doubled down here, a sign their conviction in the growth curve hasn't wavered as the company scaled.
Numbers Worth Watching
- Practices served grew roughly 7.5x in a year, from 2,000 to 15,000
- A 70% full-automation rate on conversations, rising past 85% for top customers — a rare public number for a high-stakes, low-error-tolerance use case
- Funding scaled 3.6x from a $5.5M seed to this $20M Series A in about a year, faster than most healthcare AI startups
Watchlist Status
Vocca is not currently on the watchlist. Recommend adding it to section C5 (Voice AI / Voice Agent) — tracking how it stacks up against Prosper AI in the race to automate healthcare calls, and how fast each is expanding from "answering the phone" into full scheduling infrastructure.
Today's Takeaway
Clinic phone calls get dismissed as boring administrative overhead, but that's exactly why they're proving to be fertile ground for voice agents: clear task boundaries and measurable failure modes make ROI easy to demonstrate — easier, in fact, than open-ended customer service. Vocca's 7.5x growth in served practices in a single year suggests the "boring" use cases might be where voice agents gain their first real foothold.
References
Loading...